Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19
Clinical trial NCT04803227 · TERMINATED
Trial details
- NCT number
- NCT04803227
- Sponsor
- Histogen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2021-05-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.